Venture Capital

Ziff Davis nets a massive windfall by selling its Connectivity division, including Ookla and Speedtest, to Accenture in a deal reshaping network intelligence.

Modaxo's new brand, Aerivo, emerges from an ADB SAFEGATE acquisition, poised to enhance airport efficiency with its cloud-native Flightivity suite.

A new trial for a cell therapy targeting a rare eye disease offers hope, driven by a patient-advocate's journey and with potential to treat common AMD.

With 74,000 UK mothers losing jobs annually, a new alliance between Momcozy and AllBright uses tech and advocacy to turn the motherhood penalty into power.

The world's top beauty event returns to Paris, showcasing a major shift as ingestible ingredients and holistic wellness redefine the personal care industry.

A massive US$175M investment in EverWind is set to transform Nova Scotia into a clean energy powerhouse, with a groundbreaking Indigenous partnership at its core.

With a pivotal trial for pancreatic cancer looming, Immuneering will detail its novel 'Deep Cyclic Inhibitor' platform and strategy to investors.

Entrepreneur Daniel Gestetner discusses resilience, a $1B exit, and why true success isn't about winning at all costs in a revealing new podcast.

An R&D studio is set to demo real-time AI world generation at GDC, promising a new era of interactive entertainment that runs directly on consumer hardware.

With $14M in new funding, Firmable plans to challenge US sales tech giants by leveraging its proprietary AI-driven data and a proven global playbook.

After selling poppi to PepsiCo for $1.95B, Allison and Stephen Ellsworth hire SolComms to build their next chapter as investors and thought leaders.

HTC's VIVERSE launches a global art contest, leveraging web technology to let anyone create and view immersive 3D art without needing a VR headset.

An Israeli startup claims its 'Artificial Expert Intelligence' autonomously achieved a 3.6x speedup over a decade of human-engineered NVIDIA code.

Holman Logistics hires Laurie Johnston, a seasoned legal and HR executive, to navigate the supply chain industry's complex talent and compliance challenges.

A next-gen drug for chronic hives shows superior, faster results than the long-standing standard of care, heralding a potential shift in allergy treatment.

MARSOC veterans secure $32M for Smack Technologies, an AI lab building a 'Decision Dominance' platform designed to reshape U.S. military strategy.

With 14% growth, strategic acquisitions, and major AI advancements, Real Chemistry is redefining healthcare commercialization on its 25th anniversary.

Halia Therapeutics is betting on a novel target to fight chronic inflammation. At a key summit, it will pitch its unique approach for cancer, obesity, and Alzheimer's.

A major contract with HawkEye 360 signals Europe's urgent push for sovereign defense, using commercial satellites to monitor invisible threats from space.

Flare Therapeutics partners with Simplicis, moving from manual "human babysitting" to automated infrastructure to eliminate risk and scale drug discovery.